← Back to headlines
Pfizer and Zai Lab Secure China Approval for Cervical Cancer Therapy Tivdak
Pfizer and Zai Lab have received approval from Chinese authorities for Tivdak, their cervical cancer therapy, expanding its market reach.
9 Jun, 11:30 — 9 Jun, 11:30
Sources
Showing 1 of 1 sources
